Preoperative or intraoperative staging is often necessary in malignancy in
order to plan further treatment. Although various imaging techniques are al
ready being used, new minimally-invasive approaches, such as laparoscopy, m
ay change staging strategies. The role of laparoscopic lymph node staging o
f urological malignancies is described. Most urologists agree that the use
of laparoscopy for lymph-node staging of penile cancer or transitional-cell
carcinoma (TCC) of the bladder or upper urinary tract, as well as for rena
l tumours, has no benefit in terms of changing treatment. In patients with
testicular cancer, inguinal orchiectomy is almost always the first therapeu
tic step. In non-seminomatous tumours, inguinal orchiectomy is followed by
either retroperitoneal lymphadenectomy (LAD), chemotherapy or surveillance.
Recently, laparoscopic retroperitoneal LAD has been presented by a few cen
tres with acceptable results. In patients with localised prostate cancer, p
elvic LAD is the first operative step during radical prostatectomy, to excl
ude lymph-node metastasis. In the one-step retropubic prostatectomy, lymph
nodes are 'on the way' to the prostate. A few European and many American ur
ologists prefer the two-step perineal prostatectomy. In such cases a laparo
scopic LAD is performed according to a relevant elevation of the prostate-s
pecific antigen (PSA) and radical prostatectomy negated when lymph nodes ar
e positive. Laparoscopic lymphnode staging in urological malignancies is li
mited to a group of patients with prostate cancer who are likely to have po
sitive lymph nodes and to a few patients with testicular cancer.